HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manabu Yamazaki Selected Research

perlecan

5/2016Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
9/2014Three-dimensional visualization of perlecan-rich neoplastic stroma induced concurrently with the invasion of oral squamous cell carcinoma.
3/2013Podoplanin is a novel myoepithelial cell marker in pleomorphic adenoma and other salivary gland tumors with myoepithelial differentiation.
11/2012Parenchymal-stromal switching for extracellular matrix production on invasion of oral squamous cell carcinoma.
8/2011Differential expression of perlecan receptors, α-dystroglycan and integrin β1, before and after invasion of oral squamous cell carcinoma.
4/2009Keratinocyte growth factor colocalized with perlecan at the site of capsular invasion and vascular involvement in salivary pleomorphic adenomas.
3/2004Basement membrane-type heparan sulfate proteoglycan (perlecan) and low-density lipoprotein (LDL) are co-localized in granulation tissues: a possible pathogenesis of cholesterol granulomas in jaw cysts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manabu Yamazaki Research Topics

Disease

19Neoplasms (Cancer)
03/2022 - 09/2008
10Squamous Cell Carcinoma of Head and Neck
11/2021 - 01/2010
10Carcinoma in Situ
05/2016 - 06/2011
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2022 - 08/2011
7Carcinoma (Carcinomatosis)
01/2017 - 01/2010
6Schizophrenia (Dementia Praecox)
01/2020 - 01/2014
3Obesity
01/2018 - 01/2016
3Neoplasm Metastasis (Metastasis)
01/2017 - 01/2010
2Mouth Neoplasms (Oral Cancer)
11/2021 - 05/2020
2Pleomorphic Adenoma
03/2013 - 04/2009
2Adenoid Cystic Carcinoma (Cylindroma)
06/2010 - 01/2010
2Cysts
03/2004 - 09/2003
1Carcinogenesis
03/2022
1Tongue Neoplasms (Tongue Neoplasm)
03/2022
1Osteonecrosis (Kienbock's Disease)
08/2021
1Hyperprolactinemia
01/2020
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Oral Lichen Planus
01/2020
1Overweight
01/2018
1Weight Gain
01/2018
1Diabetes Mellitus
01/2016
1Hypertriglyceridemia
01/2016
1Hypertension (High Blood Pressure)
01/2016
1Pemphigus (Pemphigus Vulgaris)
11/2015
1Polyps
11/2015
1Rupture
10/2013
1Hemorrhage
10/2013
1Colorectal Neoplasms (Colorectal Cancer)
06/2013
1Ameloblastoma
03/2012
1Odontogenic Tumors (Dental Tissue Neoplasm)
03/2012
1Adenoameloblastoma
03/2012
1Mucoepidermoid Carcinoma
06/2010
1Acinar Cell Carcinoma
06/2010
1Lymphatic Metastasis
06/2010
1Prostatic Neoplasms (Prostate Cancer)
01/2010

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
03/2022 - 04/2009
8Keratins (Keratin)IBA
01/2020 - 09/2003
7perlecanIBA
05/2016 - 03/2004
4Messenger RNA (mRNA)IBA
03/2022 - 03/2004
4ParaffinIBA
01/2017 - 06/2012
3Keratin-17 (Keratin 17)IBA
01/2020 - 06/2011
3Adenosine Triphosphate (ATP)IBA
01/2020 - 04/2009
3Antipsychotic Agents (Antipsychotics)IBA
01/2020 - 01/2018
3CholesterolIBA
01/2020 - 03/2004
3Formaldehyde (Formol)FDA Link
01/2017 - 06/2013
3Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
05/2016 - 03/2004
2oxidized low density lipoproteinIBA
01/2016 - 03/2004
2Keratin-13 (Keratin 13)IBA
06/2012 - 06/2011
2IntegrinsIBA
03/2012 - 08/2011
1Estrogen ReceptorsIBA
11/2021
1Estradiol (Delestrogen)FDA LinkGeneric
11/2021
1SteroidsIBA
11/2021
1Cathepsin BIBA
08/2021
1Lysosomal-Associated Membrane Protein 1IBA
08/2021
1Indicators and Reagents (Reagents)IBA
08/2021
1NSC 23766IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
11/2018
1Biomarkers (Surrogate Marker)IBA
11/2018
1HDL CholesterolIBA
01/2018
1HDL LipoproteinsIBA
01/2018
1Olanzapine (Zyprexa)FDA Link
01/2018
1Risperidone (Risperdal Consta)FDA LinkGeneric
01/2018
1Aripiprazole (Abilify)FDA Link
01/2018
1Biological ProductsIBA
01/2017
1moesinIBA
01/2017
1radixinIBA
01/2017
1ezrinIBA
01/2017
1Claudin-1IBA
11/2016
1Cadherins (E-Cadherin)IBA
11/2016
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2016
1Immunologic Factors (Immunomodulators)IBA
01/2016
1Desmoglein 3IBA
11/2015
1AutoantibodiesIBA
11/2015
1DesmogleinsIBA
11/2015
1Immunoglobulin G (IgG)IBA
11/2015
1Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
07/2015
1PAR-2 ReceptorIBA
07/2015
1MucinsIBA
08/2013
1Glycoproteins (Glycoprotein)IBA
08/2013
1Codon (Codons)IBA
06/2013
1ErbB Receptors (EGF Receptor)IBA
06/2013
1Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2013
1Hyaluronic Acid (Hyaluronan)IBA
03/2013
1TenascinIBA
11/2012
1Collagen Type IV (Type IV Collagen)IBA
05/2012
1Fibronectins (Fibronectin)IBA
03/2012
1Proliferating Cell Nuclear Antigen (PCNA)IBA
03/2012
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2012
1Dystroglycans (Dystroglycan)IBA
08/2011
1GemininIBA
06/2010
1DNA (Deoxyribonucleic Acid)IBA
01/2010
1Insulin-Like PeptidesIBA
01/2010
1Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2010
1Neutralizing AntibodiesIBA
01/2010

Therapy/Procedure

4Therapeutics
11/2021 - 06/2013
3Drug Therapy (Chemotherapy)
01/2016 - 04/2009
1Chemoradiotherapy
08/2021
1Mandibular Osteotomy
08/2021